Valproic acid 250 MG Oral Capsule — RxCUI 1099681
RxNorm drug concept · Semantic clinical drug
RxCUI 1099681
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
28 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1099681
Official nameValproic acid 250 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asVPA 250 MG Oral Capsule
FDA products mapped11
Package NDCs mapped28
Reported Medicaid activity (SDUD)54,608 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Divalproex: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Divalproex is used for three main things: controlling certain types of seizures (epilepsy), treating acute manic or mixed episodes in bipolar disorder, and preventing migraines. Wh...
- What exactly is divalproex used for — my doctor prescribed it but I'm not totally sure why.
- That depends on your specific form. If you're taking the extended-release tablet, you take it once a day and should swallow it whole — don't crush or chew it. The delayed-release t...
- How should I take it — does it matter when during the day or whether I eat first?
🕸️ Concept Web — How Valproic acid 250 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Valproic acid 250 MG Oral Capsule
RxCUI 1099681 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Valproate
40254IN -
Valproic acid
11118PIN
-
Valproate
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Valproate Oral Capsule
808650SCDF -
Valproic acid Oral Capsule
2649456SCDFP -
Valproate Oral Product
1159996SCDG -
Valproate Pill
1159997SCDG -
Valproic acid Oral Product
2661591SCDGP -
Valproic acid Pill
2660253SCDGP -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Valproate Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Valproic acid 250 MG
1099669SCDC
-
Valproic acid 250 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Valproic acid 250 MG
SCDC · 1099669 -
Valproate Oral Capsule
SCDF · 808650 -
Valproic acid Oral Capsule
SCDFP · 2649456 -
Valproate Oral Product
SCDG · 1159996 -
Valproate Pill
SCDG · 1159997 -
Valproic acid Oral Product
SCDGP · 2661591 -
Valproic acid Pill
SCDGP · 2660253
📦 FDA Products & Package NDCs
11 products · 28 package NDCs
28 package NDCs map to RxCUI 1099681 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-4012-01 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-4012-01) | Valproic | Actavis Pharma, Inc. | 2009-09-08 |
| 00615-8205-39 | 30 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0615-8205-39) | Valproic Acid | NCS HealthCare of KY, LLC dba Vangard Labs | 2018-03-05 |
| 00832-0310-11 | 100 CAPSULE in 1 BOTTLE (0832-0310-11) | valproic acid | Upsher-Smith Laboratories, LLC | 2015-02-09 |
| 17856-0152-01 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-0152-1) / 1 CAPSULE, L... | Valproic Acid | ATLANTIC BIOLOGICALS CORP. | 2021-06-25 |
| 43353-0085-53 | 60 CAPSULE in 1 BOTTLE (43353-085-53) | valproic acid | Aphena Pharma Solutions - Tennessee, LLC | 2015-07-20 |
| 43353-0085-60 | 90 CAPSULE in 1 BOTTLE (43353-085-60) | valproic acid | Aphena Pharma Solutions - Tennessee, LLC | 2015-07-20 |
| 43353-0085-70 | 120 CAPSULE in 1 BOTTLE (43353-085-70) | valproic acid | Aphena Pharma Solutions - Tennessee, LLC | 2015-12-16 |
| 43353-0085-80 | 180 CAPSULE in 1 BOTTLE (43353-085-80) | valproic acid | Aphena Pharma Solutions - Tennessee, LLC | 2015-12-15 |
| 43353-0085-90 | 240 CAPSULE in 1 BOTTLE (43353-085-90) | valproic acid | Aphena Pharma Solutions - Tennessee, LLC | 2016-05-23 |
| 43353-0085-94 | 360 CAPSULE in 1 BOTTLE (43353-085-94) | valproic acid | Aphena Pharma Solutions - Tennessee, LLC | 2015-10-28 |
| 43353-0279-53 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43353-279-53... | Valproic Acid | Aphena Pharma Solutions - Tennessee, LLC | 2017-02-11 |
| 43353-0279-60 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43353-279-60... | Valproic Acid | Aphena Pharma Solutions - Tennessee, LLC | 2017-02-11 |
| 43353-0279-70 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43353-279-7... | Valproic Acid | Aphena Pharma Solutions - Tennessee, LLC | 2017-02-16 |
| 43353-0279-80 | 180 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43353-279-8... | Valproic Acid | Aphena Pharma Solutions - Tennessee, LLC | 2017-02-11 |
| 43353-0279-90 | 240 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43353-279-9... | Valproic Acid | Aphena Pharma Solutions - Tennessee, LLC | 2017-04-25 |
| 43353-0279-94 | 360 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43353-279-9... | Valproic Acid | Aphena Pharma Solutions - Tennessee, LLC | 2017-03-07 |
| 63629-2454-01 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (63629-2454-... | Valproic Acid | Bryant Ranch Prepack | 2025-01-24 |
| 69452-0150-20 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (69452-150-2... | Valproic Acid | Bionpharma Inc. | 2016-07-15 |
| 70518-0079-00 | 30 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (70518-0079-0) | Valproic Acid | REMEDYREPACK INC. | 2016-12-23 |
| 70518-0079-01 | 100 POUCH in 1 BOX (70518-0079-1) / 1 CAPSULE, LIQUID FILLE... | Valproic Acid | REMEDYREPACK INC. | 2020-06-11 |
| 70518-0079-03 | 50 POUCH in 1 BOX (70518-0079-3) / 1 CAPSULE, LIQUID FILLED... | Valproic Acid | REMEDYREPACK INC. | 2026-04-23 |
| 71610-0906-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (71610-906-30) | Valproic | Aphena Pharma Solutions - Tennessee, LLC | 2025-05-07 |
| 71610-0906-53 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (71610-906-53) | Valproic | Aphena Pharma Solutions - Tennessee, LLC | 2025-05-07 |
| 71610-0906-60 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (71610-906-60) | Valproic | Aphena Pharma Solutions - Tennessee, LLC | 2025-05-07 |
| 71610-0906-70 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (71610-906-70) | Valproic | Aphena Pharma Solutions - Tennessee, LLC | 2025-05-23 |
| 71610-0906-80 | 180 CAPSULE, LIQUID FILLED in 1 BOTTLE (71610-906-80) | Valproic | Aphena Pharma Solutions - Tennessee, LLC | 2025-05-07 |
| 71610-0906-90 | 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (71610-906-90) | Valproic | Aphena Pharma Solutions - Tennessee, LLC | 2025-05-23 |
| 72189-0010-30 | 30 CAPSULE in 1 BOTTLE (72189-010-30) | Valproic Acid | Direct_Rx | 2019-06-21 |
Observed labelers:
Aphena Pharma Solutions - Tennessee, LLC (18) ·
REMEDYREPACK INC. (3) ·
Actavis Pharma, Inc. (1) ·
ATLANTIC BIOLOGICALS CORP. (1) ·
Bionpharma Inc. (1) ·
Bryant Ranch Prepack (1)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.